Virus-specific alterations in placental structure and transporter expression following maternal arbovirus infection.

Virus-specific alterations in placental structure and transporter expression following maternal arbovirus infection.

Publication date: Jul 31, 2026

We hypothesized that arboviruses impair the placental expression of key functional markers implicated in fetal brain development. Singleton placentae (n = 54) affected by chikungunya (CHIKV, n = 12), dengue (DENV, n = 8), zika (ZIKV, n = 15), or healthy controls (HC, n = 15) were analysed. Immunohistochemical quantification of key transporter systems, cell turnover markers, and signalling pathways related to extracellular matrix remodelling, vascular maintenance, and nutrient sensing was undertaken. Maternal age and BMI were lower in CHIKV/ZIKV, whereas birth weight was reduced in DENV pregnancies compared with HC. CHIKV/ZIKV exhibited reduced syncytiotrophoblast area, CHIKV/DENV showed reduced syncytial knot area, whereas DENV showed increased fetal blood vessel and reduced connective tissue areas. Histopathology detected predominantly mild vascular and stromal lesions across groups, with DENV placentae exhibiting moderate congestion in 100% of cases. Decreased expression of P-gp, BCRP, ABCA1 and SNAT2 were detected in all groups. CHIKV/ZIKV also exhibited decreased GLUT1, while ZIKV showed reduced SNAT1 expression. MCT8 expression was significantly elevated in CHIKV. Placental Ki-67 was increased in CHIKV/ZIKV, indicating altered trophoblast turnover. VEGFB expression was reduced and p-mTOR signalling was increased across all arbovirus-exposed placentae, while MMP9 expression was unchanged. Principal components analysis (PCA) distinguished infected from uninfected groups based on placental functional markers related to fetal brain development, but not on histomorphometry. Arboviral-infected placentae showed distinct structural remodelling and altered transporter expression, potentially increasing fetal brain vulnerability and long-term neurodevelopmental risks, even in the absence of neonatal symptoms. KEY POINTS: Virus-specific placental histomorphometric changes were detected, including altered syncytiotrophoblast/syncytial knot, connective tissue and fetal blood vessel areas. Arboviruses reduced the placental efflux transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) and disrupted the expression of ABCA1, SNAT2, GLUT1 and SNAT4 nutrient transporters, while ZIKV additionally reduced SNAT1 expression. Placental functional adaptation to arboviral infection comprised changes in the expression of placental markers of proliferation (Ki-67), angiogenesis (VEGFB), and nutrient sensing (p-mTOR). Arbovirus-exposed placentae exhibited greater functional alterations rather than overt structural pathology, suggesting potential subclinical effects on fetal neurodevelopment, even in the absence of major neonatal abnormalities.

Open Access PDF

Concepts Keywords
ABC transporters
arboviruses
neurodevelopmental programming
nutrient transport
placental transporters

Semantics

Type Source Name
disease MESH dengue
disease MESH arbovirus infection
disease MESH birth weight
pathway REACTOME MTOR signalling
drug DRUGBANK Pidolic Acid
disease MESH PCA
disease MESH infection
drug DRUGBANK Ribostamycin
drug DRUGBANK Hyaluronic acid
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH bites
disease MESH Anon
disease MESH fever
disease MESH rash
disease MESH arthralgia
disease MESH death
disease MESH sepsis
disease MESH miscarriage
disease MESH preterm birth
disease MESH encephalopathy
disease MESH malnutrition
disease MESH autism
disease MESH emesis
disease MESH headache
disease MESH myalgia
disease MESH oligohydramnios
disease MESH stillbirth
disease MESH neonatal death
disease MESH encephalitis
disease MESH anencephaly
disease MESH encephalocele
disease MESH microcephaly
disease MESH ZIKV infection
disease MESH conjunctivitis
disease MESH eye pain
disease MESH asymptomatic infection
disease MESH seizures
disease MESH atrophy
disease MESH cerebellar hypoplasia
disease MESH ventriculomegaly
disease MESH congenital defects
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Abacavir
drug DRUGBANK Sirolimus
pathway REACTOME Metabolism
disease MESH necrosis
disease MESH thrombosis
drug DRUGBANK Sulodexide
disease MESH gestational hypertension
disease MESH preeclampsia
disease MESH intrauterine growth restriction
disease MESH fetal death
disease MESH emergency
disease MESH erythema
disease MESH NS5
disease MESH included
drug DRUGBANK Formaldehyde
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH image
disease MESH infarction
drug DRUGBANK Hydrogen peroxide
drug DRUGBANK Sodium Citrate
disease MESH PBS
drug DRUGBANK Biotin
drug DRUGBANK Aspartame
pathway KEGG ABC transporters

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *